×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: nexium | generic | heartburn | fda

Generic Version of Heartburn Drug Nexium OKd by FDA

Monday, 26 January 2015 04:24 PM

The U.S. Food and Drug Administration said it approved Teva Pharmaceutical's generic version of AstraZeneca's blockbuster heartburn drug Nexium, the agency's first such approval for the drug.

The approval comes as generic drugmakers scramble to get their versions to the market and AstraZeneca is taken to court over so-called "pay-for-delay" settlements to delay the launch of generics to protect its drug's exclusivity.

Nexium raked in about $1.9 billion in global sales in the first half of 2014, according to AstraZeneca's latest earnings statement.

Nexium, known chemically as esomeprazole, is a proton pump inhibitor used to reduce acid in the stomach to treat gastroesophageal reflux disease (GERD).

Teva has won approval to make 20 and 40 milligram capsules of the drug for this indication, the FDA said on Monday.

Nexium is also cleared to reduce the risk of gastric ulcers associated with use of non-steroidal anti-inflammatory drugs, to fight the stomach infection Helicobacter pylori, and for use in other conditions where the stomach makes too much acid.

Last month a U.S. federal court ruled it was not anticompetitive for AstraZeneca and India's Ranbaxy Laboratories Ltd to agree to delay the launch of a Nexium generic.

The plaintiffs claim the settlement gave Ranbaxy nearly $1 billion to delay the launch of its generic.

The suit originally also targeted Teva and another Indian generic drugmaker Dr. Reddy's Laboratories, which reached deals with AstraZeneca. Both settled with the plaintiffs.

In November, a U.S. court had denied Ranbaxy's request to prevent U.S-based Endo International and Dr. Reddy's from making generics after the FDA gave the duo approvals to launch their own copies.

Ranbaxy had planned to launch generic Nexium last year, but the FDA revoked its approval citing problems with the company's manufacturing process.

© 2022 Thomson/Reuters. All rights reserved.


Health-News
The U.S. Food and Drug Administration said it approved Teva Pharmaceutical's generic version of AstraZeneca's blockbuster heartburn drug Nexium, the agency's first such approval for the drug. The approval comes as generic drugmakers scramble to get their versions to the market...
nexium, generic, heartburn, fda
289
2015-24-26
Monday, 26 January 2015 04:24 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved